Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Price
Dec 12, 2012 Pres, CEO Cooper Medical, Inc. Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,166 --
Dec 11, 2013 VP, CFO & CRO Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,196 --
Dec 11, 2013 VP & Chief Strategy Officer Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,196 --
Jul 11, 2005 Director Open market or private sale of non-derivative or derivative security 8,199 $65.00
Jul 11, 2005 Director Open market or private sale of non-derivative or derivative security 8,199 $65.00
Dec 11, 2018 President, CSI Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,236 --
Jan 03, 2017 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,250 $28.52
Jan 03, 2017 Director Open market or private sale of non-derivative or derivative security 8,250 $175.56
Jan 03, 2017 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,250 --
Sep 26, 2012 Pres, CEO Cooper Medical, Inc. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,250 $42.65
Sep 26, 2012 Pres, CEO Cooper Medical, Inc. Open market or private sale of non-derivative or derivative security 8,250 $94.12
Sep 26, 2012 Pres, CEO Cooper Medical, Inc. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,250 --
Jun 19, 2012 Pres, CEO Cooper Medical, Inc. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,250 $42.65
Jun 19, 2012 Pres, CEO Cooper Medical, Inc. Open market or private sale of non-derivative or derivative security 8,250 $80.00
Jun 19, 2012 Pres, CEO Cooper Medical, Inc. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,250 --
Apr 07, 2011 Pres & COO - CSI Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,250 $13.21
Apr 07, 2011 Pres & COO - CSI Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,250 --
Dec 10, 2010 Director Open market or private sale of non-derivative or derivative security 8,250 $57.24
Dec 10, 2010 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,250 $28.52
Dec 10, 2010 Director Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 8,250 --
Nov 02, 2009 Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,250 --
Nov 02, 2009 Director Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,250 --
Dec 10, 2008 President Americas, CVI Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,250 --
Oct 30, 2008 President Americas, CVI Grant, award or other acquisition pursuant to Rule 16b-3(d) 8,250 --
Sep 19, 2005 Director, President & CEO Open market or private sale of non-derivative or derivative security 8,300 $74.40

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.